It was a pleasure to catch up with our valued Editorial Board member, J Fernando Arevalo (Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA), who gave his insights on his topic at the retina subspecialty day at AAO 2020, intravitreal anti-VEGF injections for exudative retinal arterial macroaneurysms.
Questions
- Could you give us a brief overview of exudative retinal arterial macroaneurysms and their prognosis? (00:24)
- What are the current treatment options for exudative retinal arterial macroaneurysms? (02:21)
- What are the advantages of intravitreal anti-VEGF therapy compared with direct laser photocoagulation? (02:49)
- Could you tell us about your retrospective international multicentre study and its findings? (04:07)
- What are the implications of these findings for future clinical practice? (06:45)
Speaker Disclosure: Dr J Fernando Arevalo has no financial or non-financial relationships or activities to declare in relation to this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of AAO 2020.
